Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Meloxicam is an enol nonsteroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects.Selective inhibition of cox-2 (cox-2), the inhibition of cox-1 is weak, so the digestive system and other adverse reactions are less.
The global Meloxicam market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Meloxicam volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Meloxicam market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Meloxicam Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
by Ingredient
Combination Drugs
Prescribed Drugs
by Route
Oral
Intravenou
by Dosage Form
Tablets
Capsule
Granules
Other
Segment by Application
Rheumatoid Arthritis
Osteoarthritis
Soft Tissue Inflammation
Traumatic Pain
Post-Operative Pain
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Boehringer Ingelheim
Baudax
Perrigo
Recro Pharma
Iroko Pharma
Zyla Life Sciences
Axsome Therapeutics
Orbis Biosciences
Cellix Bio
Ligand Pharma
SEDOR Pharma
Heron Therapeutics
Pacira BioSciences
Sanofi
Eurofarma Laboratorio
TerSera Therapeutics
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Zydus Pharmaceuticals
Unichem Pharmaceuticals
Strides Pharma
Cipla
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
TARO
Lupin Pharmaceuticals
Aurobindo Pharma
Shanghai Bolinger Ingelheim Pharmaceutical
Shanghai Zhaohui Pharmaceutical
Sichuan Shenghe Pharmaceutical
Ningxia Kangya Pharmaceutical
Yangtze Pharmaceutical Group
Kunshan Longdeng Ruidi Pharmaceutical
Jiangsu Yabang Epson Pharmaceutical
Jiangsu Feima Pharmaceutical Co. , Ltd
Zhejiang Xianju Pharmaceutical
Hainan All Star Pharmaceutical
The global Meloxicam market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Meloxicam volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Meloxicam market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Meloxicam Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
by Ingredient
Combination Drugs
Prescribed Drugs
by Route
Oral
Intravenou
by Dosage Form
Tablets
Capsule
Granules
Other
Segment by Application
Rheumatoid Arthritis
Osteoarthritis
Soft Tissue Inflammation
Traumatic Pain
Post-Operative Pain
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Boehringer Ingelheim
Baudax
Perrigo
Recro Pharma
Iroko Pharma
Zyla Life Sciences
Axsome Therapeutics
Orbis Biosciences
Cellix Bio
Ligand Pharma
SEDOR Pharma
Heron Therapeutics
Pacira BioSciences
Sanofi
Eurofarma Laboratorio
TerSera Therapeutics
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Zydus Pharmaceuticals
Unichem Pharmaceuticals
Strides Pharma
Cipla
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
TARO
Lupin Pharmaceuticals
Aurobindo Pharma
Shanghai Bolinger Ingelheim Pharmaceutical
Shanghai Zhaohui Pharmaceutical
Sichuan Shenghe Pharmaceutical
Ningxia Kangya Pharmaceutical
Yangtze Pharmaceutical Group
Kunshan Longdeng Ruidi Pharmaceutical
Jiangsu Yabang Epson Pharmaceutical
Jiangsu Feima Pharmaceutical Co. , Ltd
Zhejiang Xianju Pharmaceutical
Hainan All Star Pharmaceutical
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
